Literature DB >> 10640200

Nasopharyngeal angiofibroma: true neoplasm or vascular malformation?

A Beham1, C Beham-Schmid, S Regauer, L Auböck, H Stammberger.   

Abstract

Nasopharyngeal angiofibromas (NA) are rare tumor-like lesions characterized by architecturally irregular vessels set in a fibrous stroma. The unique morphology, the strong predilection for male adolescents, and the uncertainty about its etiology contributes to significant confusion regarding the classification of NA, which still has not been solved today. Based on immunohistochemical and electron microscopic examinations, we demonstrate in detail the various unusual vascular architectural features of NA. They represent discontinuous vascular basal laminae, focal lack of pericytes, and pronounced irregularity of the smooth muscle layers. In thick smooth muscle layers and pads, the orientation of muscle cells is frequently disturbed, and the individual cells differ in size and shape. Occasionally, the muscle layers disperse peripherally into individual cells, creating the impression of vessel-independent smooth muscle cells within the stroma. The summation of all morphological irregularities demonstrated in this paper allows the conclusion that NA represent vascular malformations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640200     DOI: 10.1097/00125480-200007010-00006

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  18 in total

1.  [Comparative genomic hybridization as cytogenetic tumor diagnosis technique in juvenile angiofibroma].

Authors:  H Löwenheim
Journal:  HNO       Date:  2003-12       Impact factor: 1.284

2.  Nasopharyngeal angiofibroma of the nasal cavity.

Authors:  S Marc Stokes; James T Castle
Journal:  Head Neck Pathol       Date:  2010-05-13

3.  Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features.

Authors:  Celeste Sánchez-Romero; Roman Carlos; Juan Pablo Díaz Molina; Lester D R Thompson; Oslei Paes de Almeida; Alicia Rumayor Piña
Journal:  Head Neck Pathol       Date:  2017-05-15

4.  Combined percutaneous and transarterial devascularisation of juvenile nasopharyngeal angiofibroma with protection of internal carotid artery: A modification of the technique.

Authors:  Ljubisa Borota; Ehab Mahmoud; Christoffer Nyberg; Tomas Ekberg
Journal:  Interv Neuroradiol       Date:  2015-05-19       Impact factor: 1.610

5.  [Angiographic evaluation and embolization of juvenile nasopharyngeal angiofibroma].

Authors:  C Giavroglou; J Constantinidis; S Triaridis; J Daniilidis; A Dimitriadis
Journal:  HNO       Date:  2007-01       Impact factor: 1.284

6.  Preliminary analysis of different microRNA expression levels in juvenile angiofibromas.

Authors:  Cornelia Lerner; Silke Wemmert; Bernhard Schick
Journal:  Biomed Rep       Date:  2014-08-19

7.  Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.

Authors:  Suely Nonogaki; Heloisa G A Campos; Ossamu Butugan; Fernando A Soares; Flávia Regina Rotea Mangone; Humberto Torloni; M Mitzi Brentani
Journal:  Exp Ther Med       Date:  2010-08-26       Impact factor: 2.447

Review 8.  True bilateral nasopharyngeal angiofibroma: report and review.

Authors:  Anupam Mishra; Subhash Chandra Mishra
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-08       Impact factor: 2.503

9.  Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.

Authors:  Silke Wemmert; Vivienne Willnecker; Philipp Kulas; Stefanie Weber; Cornelia Lerner; Sabrina Berndt; Olaf Wendler; Bernhard Schick
Journal:  Tumour Biol       Date:  2015-11-17

Review 10.  Update on hemangiomas and vascular malformations of the head and neck.

Authors:  Behfar Eivazi; Mircia Ardelean; Wolfgang Bäumler; Hans-Peter Berlien; Hansjörg Cremer; Ravindhra Elluru; Peter Koltai; Jan Olofsson; Gresham Richter; Bernhard Schick; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.